全文获取类型
收费全文 | 861366篇 |
免费 | 71437篇 |
国内免费 | 1839篇 |
专业分类
耳鼻咽喉 | 12799篇 |
儿科学 | 24626篇 |
妇产科学 | 25098篇 |
基础医学 | 124221篇 |
口腔科学 | 25485篇 |
临床医学 | 75331篇 |
内科学 | 164575篇 |
皮肤病学 | 16977篇 |
神经病学 | 70102篇 |
特种医学 | 35200篇 |
外国民族医学 | 171篇 |
外科学 | 136154篇 |
综合类 | 24606篇 |
现状与发展 | 2篇 |
一般理论 | 263篇 |
预防医学 | 66917篇 |
眼科学 | 20519篇 |
药学 | 64731篇 |
中国医学 | 1593篇 |
肿瘤学 | 45272篇 |
出版年
2018年 | 7332篇 |
2015年 | 7724篇 |
2014年 | 11108篇 |
2013年 | 16779篇 |
2012年 | 22725篇 |
2011年 | 23832篇 |
2010年 | 13867篇 |
2009年 | 13063篇 |
2008年 | 22572篇 |
2007年 | 24632篇 |
2006年 | 24494篇 |
2005年 | 24158篇 |
2004年 | 23713篇 |
2003年 | 22841篇 |
2002年 | 21930篇 |
2001年 | 35825篇 |
2000年 | 36470篇 |
1999年 | 30899篇 |
1998年 | 9226篇 |
1997年 | 8549篇 |
1996年 | 8482篇 |
1995年 | 8008篇 |
1994年 | 7724篇 |
1992年 | 26667篇 |
1991年 | 26107篇 |
1990年 | 25620篇 |
1989年 | 24680篇 |
1988年 | 23225篇 |
1987年 | 22885篇 |
1986年 | 21742篇 |
1985年 | 21102篇 |
1984年 | 16385篇 |
1983年 | 14000篇 |
1982年 | 8855篇 |
1981年 | 8202篇 |
1980年 | 7673篇 |
1979年 | 16738篇 |
1978年 | 12116篇 |
1977年 | 10182篇 |
1976年 | 9332篇 |
1975年 | 10150篇 |
1974年 | 12643篇 |
1973年 | 12137篇 |
1972年 | 11538篇 |
1971年 | 10686篇 |
1970年 | 10218篇 |
1969年 | 9909篇 |
1968年 | 8900篇 |
1967年 | 8234篇 |
1966年 | 7653篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
C C Johnson T A Nicklas M L Arbeit D W Harsha D S Mott S M Hunter W Wattigney G S Berenson 《Southern medical journal》1991,84(11):1305-1312
The Heart Smart Family Health Promotion Program is a multidisciplinary, school-based program for cardiovascular risk reduction among high-risk children and their families. As a program that includes young adults at high risk, it is adaptable to a clinical practice. Nineteen fourth and fifth graders were selected as probands for elevated risk factors after a general screening to identify families for an intervention program. Twenty-three parents participated in a 12-week program focused on eating, exercise, and smoking behavior changes enhanced by behavicral support strategies. Weekly sessions were held in the auditorium/cafeteria of the elementary school and consisted of orientation and presentations, cardiovascular (CV) screening with medical feedback, activities, self-monitoring, counseling, and contingency contracting. Information gathered before and after the program included medical history, CV health knowledge and relevant behavior, blood pressure, serum lipid and lipoprotein values, anthropometric measurements, and urine electrolyte excretion. Both children and parents showed positive changes in eating habits and physical activity and significant changes in knowledge and blood pressure levels, while the children halted their weight gain. We believe this multidisciplinary, behavior-oriented, school-based program can be an effective cardiovascular risk intervention adaptable for a clinical office practice. 相似文献
992.
Computed tomography (CT) was performed in 14 cases of tuberculous meningitis (TBM), 12 of which were examined during the acute phase of the disease. CT findings in these cases included internal hydrocephalus (6/12), internal combined with external hydrocephalus (2/12), focal lesions consistent with localized encephalitis (3/12), diffuse brain edema (1/12), and middle cerebral artery infarction (1/12). In comparison to 32 cases of nonspecific bacterial meningitis, internal hydrocephalus was found significantly more often in TBM than in nonspecific meningitis (p less than 0.01) making CT an additional tool for the differentiation of these conditions in doubtful cases. In addition, CT features of 2 cases of cerebral tuberculoma are presented. 相似文献
993.
994.
Hypoxic ischemic encephalopathy (asphyxia) 总被引:2,自引:0,他引:2
A W Brann 《Pediatric clinics of North America》1986,33(3):451-464
This article concerns itself with the effects of HIE on the brain of the full-term infant. Several treatment options are available, with phenobarbital being the drug of choice, but the course remains observation and careful monitoring of the at-risk infant. 相似文献
995.
996.
Keith J Murphy Andrew G Foley Alan W O'connell Ciaran M Regan 《Neuropsychopharmacology》2006,31(1):90-100
Recent data suggest that Alzheimer's patients who discontinue treatment with cholinesterase inhibitors have a significantly delayed cognitive decline as compared to patients receiving placebo. Such observations suggest cholinesterase inhibitors to provide a disease-modifying effect as well as symptomatic relief and, moreover, that this benefit remains after drug withdrawal. Consistent with this suggestion, we now demonstrate that chronic administration of tacrine, nefiracetam, and deprenyl, drugs that augment cholinergic function, increases the basal frequency of dentate polysialylated neurons in a manner similar to the enhanced neuroplasticity achieved through complex environment rearing. While both drug-treated and complex environment reared animals continue to exhibit memory-associated activation of hippocampal polysialylated neurons, the magnitude is significantly reduced suggesting that such interventions induce a more robust memory pathway that can acquire and consolidate new information more efficiently. This hypothesis is supported by our findings of improved learning behavior and enhanced resistance to cholinergic deficits seen following either intervention. Furthermore, the level of enhancement of basal neuroplastic status achieved by either drug or environmental intervention correlates directly with improved spatial learning ability. As a combination of both interventions failed to further increase basal polysialylated cell frequency, complex environment rearing and chronic drug regimens most likely enhanced cognitive performance by the same mechanism(s). These findings suggest that improved memory-associated synaptic plasticity may be the fundamental mechanism underlying the disease modifying action of drugs such as cholinesterase inhibitors. Moreover, the molecular and cellular events underpinning neuroplastic responses are identified as novel targets in the search for interventive drug strategies for the treatment of neurodegenerative and neuropsychiatric disorders. 相似文献
997.
Lucy Wong-Hernandez Daniel W. Wong G. Ben Selby 《中国康复理论与实践》2006,12(9):758-761
1Introduction Substanceabusecontinuestobeamongthemostsevereso cialandcostlyhealthproblemsdevastatingindividualsandtheir familiesintheUnitedStates.Initssimplestdefinition,sub stanceabuseisthecontinueduseofalcoholorotherdrugsde spiteknowledgeofhavingapersistentsocial,vocational,psy chologicalorphysicalproblemthatiscausedorexacerbatedby theuseofalcoholorotherdrugs(DSMIV TR,1994).All drugsofabuse,includingalcohol,aretoxicandcannegatively impacteverysysteminthehumanorganism.Protractedsub stance… 相似文献
998.
999.
Nicholas L. Shortt Gary F. Keenan Andrew Y. Muir Prof. Dr. A. Hamish R. W. Simpson 《Operative Orthopadie und Traumatologie》2006,18(4):364-376
OBJECTIVE: Avoidance of potential iatrogenic nerve injury during insertion of Ilizarov fine wires into areas of high anatomic risk by using a modified nerve stimulation technique. INDICATIONS: Application of the Ilizarov ring fixator to areas of high anatomic hazard, in situations where anatomic topography may be distorted by previous surgery, trauma, or congenital anomalies. CONTRAINDICATIONS: Use of systemic muscle relaxants. Caution in patient with cardiac pacemaker. SURGICAL TECHNIQUE: Preliminary experiments showed that a standard nerve-stimulating device can deliver a negatively charged, monophasic square pulse of current through Ilizarov wires. During the application of an Ilizarov frame to potentially hazardous anatomic regions, providing no systemic muscle relaxants are used, a voltage field sufficient to cause nerves in close proximity to the Ilizarov wire to depolarize is produced. Identification of a distal muscle twitch provoked by the stimulation may indicate a potential for iatrogenic nerve injury. RESULTS: Results show that with the nerve stimulator set at 2.5 mA (pulsed at a frequency of 2 Hz), peripheral nerves are stimulated if they lie within 5 mm of the wires. Should a distal muscle twitch occur, wires should be repositioned so that equivalent stimulation produces no twitch. The technique was used during Ilizarov frame application in ten patients, with only a single occurrence of distal muscle twitches in a lower-leg frame. Following repositioning of the Ilizarov wire in this case, no further twitches were observed, indicating that no Ilizarov wire was inserted close to peripheral nerves. No neurologic impairment was present postoperatively. 相似文献
1000.
A T Farrell I Papadouli A Hori M Harczy B Harrison W Asakura M Marty R Dagher R Pazdur 《Annals of oncology》2006,17(6):889-896
PURPOSE: This paper summarizes the role of external advisors in oncology drug development and regulation from a global perspective. DESIGN: Recently, representatives from the United States Food and Drug Administration, European Medicines Agency, the Japanese Pharmaceuticals and Medical Devices Agency, the Australian Therapeutic Goods Administration and Health Canada held a meeting in conjunction with the American Society of Clinical Oncology meeting. The role of external advisors in oncology drug development and regulation in each of these jurisdictions was presented and discussed. RESULTS: All regulatory bodies described have experience with two forms of outside expertise: advice from individual experts and advice from a group of experts assembled as an advisory group. Regulatory jurisdictions use individual experts variably. In some regions, individual experts provide advice based on knowledge and experience during the drug development phase or in the planning phase for the submission of a drug registration package. In other regions, these individuals serve as external evaluators with the primary responsibility for the review of a clinical trials package submitted for drug registration. Advisory boards have been formalized in all jurisdictions discussed. Advisory boards have a role in discussing specific applications as well as broad policy issues. A common theme is a composition of a core panel of experts with augmentation by additional expertise as needed for consideration of specific scientific questions. In all jurisdictions, advisory board recommendations are not binding on the regulatory body. CONCLUSIONS: Global oncology drug development and registration involves the use of experts by regulatory authorities. The types of experts needed, the expert's role and the transparency of the advisory process reflect the individual needs in different regions. 相似文献